The Function of GPT2 in Tumor Progression
Cancer Plus · 2023
DOI: 10.18063/cp.393 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Plus, 2023. Verfasst von Jun Xie und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Glutamate pyruvate transaminase 2 (GPT2) is one of the GPTs and is widely used as a biomarker of hepatocellular injury, along with GPT1. GPT2, a glutamine-metabolizing transaminase found in mitochondria, catalyzes the reversible process between glutamate, pyruvate, α-ketoglutarate, and alanine. Compared to GPT1, the intracellular abundance of GPT2 is higher, suggesting that its enzymatic activity has a considerable role in glucose metabolism, amino acid metabolism, and lipid metabolism. In recent years, it has been discovered that deletion or mutation of GPT2 causes malignant transformation of tumors and that its expression level is closely correlated with tumor development. It is for this reason that the level of GPT2 can be used to reflect the metabolism level of the tumor cells in the body and can indicate metastasis based on its changes. The metabolism level of GPT2 in tumor cells is expected to be a marker in the tumor diagnostic process and subsequently contribute to early detection, thus improving tumor diagnosis and patient prognosis. This paper presents an overview of the current state of GPT2 research in the progression of tumors.
Zitieren
APA
Xie, J., Shi, H., Wang, H., Li, C., & Wang, H. (2023). The Function of GPT2 in Tumor Progression. Cancer Plus. https://doi.org/10.18063/cp.393
Vancouver
Xie J, Shi H, Wang H, Li C, Wang H. The Function of GPT2 in Tumor Progression. Cancer Plus. 2023. doi:10.18063/cp.393
BibTeX
@article{Xie2023,
author = {Xie, Jun and Shi, Hongjin and Wang, Huake and Li, Chong and Wang, Haifeng},
title = {The Function of GPT2 in Tumor Progression},
journal = {Cancer Plus},
year = {2023},
doi = {10.18063/cp.393}
}
EUVIMED